Fatma Taneli

Fatma Taneli

Auto-generated profile, based on publicly available information

Fatma Taneli

Department of Clinical Biochemistry, Faculty of Medicine, Celal Bayar University, Manisa, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2020 in Cureus
Verified
Journal Article
Open access
PDF file
CSCigdem Sonmez
Cigdem Sonmez
UYUmmugulsum Yıldız
Ummugulsum Yıldız
NANedim Akkaya
Nedim Akkaya
FTFatma Taneli
Fatma Taneli
Introduction: The study intends to observe the frequency of preanalytical phase errors both inside and outside the clinical laboratory according to certain quality indicators (QIs). Methods: The one-week observation focused on 73 nurses drawing blood from 337 patients. It was performed in two stages: the observation of blood collection up to the receipt of the samples, and the receipt of the samples up to the analytical phase. The data pertaining to the number of patients, tests, and rejection rates were obtained from the laboratory information system (LIS) for the one-week and the one-year period and compared with the observational data. Results: The process of blood sample collection from 337 patients taken into 1347 tubes was observed. Although the majority of the nurses (78%) used safety needles, the safety mechanism was properly activated only in 38% of the interventions. Evaluation of biochemistry tubes (n=971) revealed the following: the incorrect fill volume error was 40%; the hemolysis was seen by 17%, and the clotted sample and fibrin were observed by 6%. The incorrect fill volume error was 12% and 20% in ethylenediaminetetraacetic acid (EDTA) and citrated tubes, respectively. Clotted samples and platelet clumps were seen in 1% of EDTA tubes. Conclusion: The study confirms the relative frequency of preanalytical phase error occurring inside and outside of the laboratory.

1 January 2016 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
GOGülay Ok
Gülay Ok
DADemet Aydin
Demet Aydin
KEKoray Erbüyün
Koray Erbüyün
CGCanan Gürsoy
Canan Gürsoy
FTFatma Taneli̇
Fatma Taneli̇
GHGönül Di̇nç Horasan
Gönül Di̇nç Horasan
Factors affecting neurological outcome and the usefulness of neuron-specific enolase (NSE), S-100B, glial fibrillary acidic protein (GFAP), and procalcitonin (PCT) in predicting neurological outcomes were assessed in patients who survived at least 24 h after cardiopulmonary resuscitation (CPR). Thirty successfully resuscitated cardiac arrest patients were included in this prospective clinical study. The initial cardiac arrest rhythm, duration of CPR, return of spontaneous circulation time, administered doses of adrenaline, base excess, blood sugar, and hemodynamic parameters were recorded. Patients with Glasgow Outcome Scale (GOS) scores of 1-3 were defined as Group I and patients with GOS scores of 4-5 were defined as Group II. Serum NSE, GFAP, S-100B, and PCT levels were compared between the two groups shortly after CPR (hour 0) and at hours 12 and 24 of the postresuscitation period. Serum S-100B was significantly higher (P = 0.009) in Group II immediately after CPR. Serum S-100B and NSE after CPR at hours 0, 12, and 24 were significantly lower in patients who survived to hospital discharge. Serum PCT at hours 12 and 24 and serum S-100B after CPR at 0, 12, and 24 h reached 94.7% sensitivity. Serum NSE, GFAP, S-100B, and PCT specificities were lower than 50%. In predicting neurological outcomes, serum S-100B has high sensitivity and low specificity immediately after CPR.

1 December 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
SSSemra Sen
Semra Sen
DKDeniz Özalp Kızılay
Deniz Özalp Kızılay
FTFatma Taneli
Fatma Taneli
ÇÖÇınar Özen
Çınar Özen
PEPelin Ertan
Pelin Ertan
BEBetül Ersoy
Betül Ersoy
Objective:Neutrophil gelatinase-associated lipocalin (NGAL) is one of the new biomarkers for detecting acute renal injury. There are studies showing the relationship between NGAL and renal injury in obese children. The aim of this study was to investigate whether urinary levels of NGAL, kidney injury molecule-1, and serum cystatin C are increased in insulin resistance (IR) patients before the development of diabetes.Methods:Cross-sectional, case-controlled study that included non-diabetic obese children and adolescent patients with IR and a non-diabetic obese control group with no IR, who attended a tertiary center pediatric endocrinology outpatient clinic between 2016-2018. Those with diabetes mellitus and/or known renal disease were excluded. NGAL and creatinine (Cr) levels were evaluated in the morning spot urine from all participants. Serum renal function was evaluated.Results:Thirty-six control and 63 IR patients were included in the study, of whom 68 (68.7%) were girls. The mean age of all participants was 13.12±2.64 years and no statistically significant difference was found between the two groups in terms of age or gender distribution. Median (range) spot urinary NGAL (u-NGAL) values in the IR group were significantly higher at 26.35 (7.01-108.7) ng/mL than in the control group at 19.5 (3.45-88.14) ng/mL (p=0.018). NGAL/Cr ratio was also significantly higher in the IR group compared to the control group (p=0.018).Conclusion:Obese pediatric patients with IR were shown to have elevated levels of u-NGAL, a marker of renal injury. u-NGAL examination may show early renal injury before development of diabetes.

5 November 2011 in Medical Principles and Practice
Verified
Journal Article
Open access
PDF file
EOEce Onur
Ece Onur
AKAdnan Taner Kurdal
Adnan Taner Kurdal
BTBerrin Tuğrul
Berrin Tuğrul
IIIhsan Iskesen
Ihsan Iskesen
PDPınar Dundar
Pınar Dundar
AVAhmet Var
Ahmet Var
Objective: To determine the risk of an association with some genetic polymorphisms involved in venous thromboembolism (VTE) gene variations (FVL, FV H1299R, FII G20210A, MTHFR C677T, MTHFR A1298C, PAI-1 4G/5G, β-fibrinogen -455 G → A, FXIII Val34Leu and GpIIIa HPA-1a) in cancer patients. Subjects and Methods: Among 78 cancer patients, 28 who had proven first episode of VTE were selected as the patient group, with 50 control samples selected from age-, sex- and body mass index-matched healthy volunteers (healthy group). The differences in frequency of genetic polymorphisms were found to be statistically insignificant between these two groups. Results: Logistic regression analysis after adjustment for age, sex, smoking and hypertension showed no difference. The screened mutations of these genes were not significantly associated with VTE risk. Conclusion: There is no possible benefit from genetic screening tests regarding VTE in cancer patients.

30 October 2017 in Urolithiasis
Verified
Journal Article
Closed access
EEEzgi Yangin Ergon
Ezgi Yangin Ergon
IAİpEk Ozunan Akil
İpEk Ozunan Akil
FTFatma Taneli
Fatma Taneli
AOArzu Oran
Arzu Oran
BOBeyhan Cengız Ozyurt
Beyhan Cengız Ozyurt

1 August 2021 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
YOYekta Ozkan
Yekta Ozkan
HKHasan Kandemir
Hasan Kandemir
SSSermin Yalın Sapmaz
Sermin Yalın Sapmaz
FTFatma Taneli
Fatma Taneli
HOHabib Ozdemir
Habib Ozdemir
OOOzge Gozaçanlar Ozkan
Ozge Gozaçanlar Ozkan